When was SubjectWell founded?

SubjectWell was founded in 2012 and raised its 1st funding round 6 years after it was founded.

Where is SubjectWell located?

SubjectWell is headquartered in Austin, United States.

How many employees does SubjectWell have?

As of Jul 31, 2026, the latest employee count at SubjectWell is 135.

Is SubjectWell a funded company?

SubjectWell is a funded company, having raised a total of $46.8M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 28, 2018.

When was the latest funding round of SubjectWell?

SubjectWell's latest funding was a $***** Series B round on Oct 20, 2022, with participation from 5 investors.

Where does SubjectWell rank among its competitors?

SubjectWell ranks 4th amongst 168 active competitors, of which 45 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was myTomorrows, which secured $29M in Nov, 2025.

Who are the top competitors of SubjectWell?

SubjectWell's top competitors include Evidation, myTomorrows and Antidote. Among them, myTomorrows secured the most recent funding round in November, 2025.

SubjectWell - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of clinical trials marketplace offering solutions for patient recruitment. It offers a technology platform that identifies patients who are interested and gives them an easy introduction to clinical trials. It alerts interested candidates to clinical trials and also offer quality referrals through prescreening.

Website: subjectwell.com
Social
Email ID: *****@subjectwell.com
Phone Number: +1 **********

Key Metrics

Founded Year

2012

Location

Austin, United States

Stage

Acquired

Total Funding

$46.8M in 3 rounds

Latest Funding Round

Series B, Oct 20, 2022, $*****

Investors

Asset Management Ventures & 11 more

Ranked

4^th among 168 active competitors

Employee Count

135 as on Jul 31, 2026

Investment & Acquisitions

Trials24 & 1 more

Similar Companies

Evidation & 240 more

Exit Details

Acquired by WindRose Health Investors (Apr 30, 2024)

View SubjectWell's full profile

SubjectWell got acquired by WindRose Health Investors on Apr 30, 2024.

Click here to take a look at SubjectWell's acquisition in detail

SubjectWell has raised a total funding of $46.8M over 3 rounds. Its first funding round was on Feb 28, 2018. Its latest funding round was a Series B round on Oct 20, 2022 for $*****. 5 investors participated in its latest round. SubjectWell has 12 institutional investors.

Here is the list of recent funding rounds of SubjectWell:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 20, 2022	1796868	Series B	2979498	7995967	7825601	6864577
Jun 18, 2019	6047430	Series A	5008662	9822390	8112888	Healthy Ventures & 1 more
Feb 28, 2018	2238347	Seed	4366043	1372606	1725137	Healthy Ventures

Access funding benchmarks and valuations. Sign up today!

View details of SubjectWell's funding rounds and investors

The founders of SubjectWell is Joel Lucas. Fred Martin is the CEO of SubjectWell.

Here are the details of SubjectWell's key team members:

Joel Lucas: Co-Founder of SubjectWell.
Fred Martin: CEO of SubjectWell.
Contact Info: 1 email address

View details of SubjectWell's Founder profiles and Board Members

SubjectWell's employee count trend

SubjectWell has 135 employees as of Jul 26. Here is SubjectWell's employee count trend over the years:

Uncover SubjectWell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SubjectWell include Evidation, myTomorrows and Antidote. Here is the list of Top 10 competitors of SubjectWell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Evidation 2012, Menlo Park (United States), Series E	Real-world health data insights for better healthcare decisions and research	$259M	B Capital, Sanofi Ventures & 16 others	74/100
2nd	myTomorrows 2012, Amsterdam (Netherlands), Series C	Platform provides access to drugs in development to patients and physicians	$51.3M	EQT, Balderton Capital & 5 others	69/100
3rd	Antidote 2010, North Miami Beach (United States), Series C	Provider of patient recruitment and matching services for clinical trials	$52M	Merck Global Health Innovation Fund, Amadeus Capital ... & 5 others	65/100
4th	SubjectWell 2012, Austin (United States), Acquired	Provider of clinical trials marketplace offering solutions for patient recruitment	$46.8M	ATP, Healthy Ventures & 10 others	60/100
5th	Dyania Health 2019, Sacramento (United States), Series A	Developer of an AI platform for healthcare data extraction and analysis	$15.3M	HealthX Ventures, Innospark & 13 others	60/100
6th	Trialbee 2010, Malmo (Sweden), Acquired	Cloud based clinical trial recruitment solutions for pharmaceutical companies, analytics, services	$27.1M	MTIP, Industrifonden & 5 others	59/100
7th	Circuit Clinical 2014, Buffalo (United States), Series C	Research site network platform focuses on patient identification, enrollment, recruitment & retention	$47.7M	LabCorp, Rochester Angel Network & 8 others	57/100
8th	Paradigm 2003, New York City (United States), Series A	Provider of clinical research healthcare services	$203M	General Catalyst, Arch Venture Partners & 7 others	55/100
9th	Leal 2017, New York City (United States), Acquired	Provider of an AI-powered platform matching cancer patients with treatment options.	$27.7M	Contour Venture Partners, Insight Partners ... & 6 others	55/100
10th	BEKHealth 2016, New York City (United States), Series C	Provider of patient screening, recruitment, and analytics solution	$15.7M	Excelerate Health Ventures, Boston Millennia Partners ... & 6 others	54/100